Travere Therapeutics
TVTX
TVTX
123 hedge funds and large institutions have $642M invested in Travere Therapeutics in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
-8
Holders Change %
-6.11%
% of All Funds
2.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
32
Reduced
49
Closed
26
Calls
$1.67M
Puts
$4.51M
Net Calls
-$2.85M
Net Calls Change
-$958K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.1M |
| 2 |
Goldman Sachs
New York
|
+$8.44M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.31M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.28M |
| 5 |
Renaissance Technologies
New York
|
+$5.57M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$8.7M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$4.61M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.51M |
| 4 |
Two Sigma Investments
New York
|
-$4.15M |
| 5 |
SCM
Scopia Capital Management
New York
|
-$4M |
